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Abstract
Over the course of HIV infection, virus replication is facilitated by the phosphorylation of HIV proteins by human ERK1 and
ERK2 mitogen-activated protein kinases (MAPKs). MAPKs are known to phosphorylate their substrates by first binding with
them at a docking site. Docking site interactions could be viable drug targets because the sequences guiding them are
more specific than phosphorylation consensus sites. In this study we use multiple bioinformatics tools to discover candidate
MAPK docking site motifs on HIV proteins known to be phosphorylated by MAPKs, and we discuss the possibility of
targeting docking sites with drugs. Using sequence alignments of HIV proteins of different subtypes, we show that MAPK
docking patterns previously described for human proteins appear on the HIV matrix, Tat, and Vif proteins in a strain
dependent manner, but are absent from HIV Rev and appear on all HIV Nef strains. We revise the regular expressions of
previously annotated MAPK docking patterns in order to provide a subtype independent motif that annotates all HIV
proteins. One revision is based on a documented human variant of one of the substrate docking motifs, and the other
reduces the number of required basic amino acids in the standard docking motifs from two to one. The proposed patterns
are shown to be consistent with in silico docking between ERK1 and the HIV matrix protein. The motif usage on HIV proteins
is sufficiently different from human proteins in amino acid sequence similarity to allow for HIV specific targeting using small-
molecule drugs.
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Introduction
ERK1 and ERK2 mitogen-activated protein kinases (MAPKs)
have been shown to increase HIV infectivity by phosphorylating a
subset of HIV proteins [1]. Prior to HIV replication, the HIV
structural protein matrix (MA) must be phosphorylated by ERK2
to allow the HIV preintegration complex to translocate to the
nucleus, where viral replication can proceed [2]. Viral replication
may also require the phosphorylation of the HIV viral infectivity
factor (Vif) by ERK1 or ERK2 [3]. Nef and Tat have been shown
to induce the ERK MAPK cascade [4,5]. ERK1/2 has been
shown to phosphorylate HIV Nef, Rev, and Tat in vitro [1], but
the roles of these phosphorylation events in HIV infectivity remain
unknown [6]. The inhibition of MAPK phosphorylation has been
shown to decrease HIV infectivity, indicating that MA and Vif
MAPK-directed phosphorylation events would make good drug
targets [1,2].
Most MAPK drugs prevent MAPKs from interacting with ATP
by blocking the conserved ATP binding site. The use of ATP
binding site in drug development raises concerns about these
drugs’ lack of specificity [7]. An ERK inhibitor, FR180204, was
deemed to selectively inhibit ERK1/2 when it failed to inhibit
seven other kinases [8]. However, with nearly 500 kinases left to
test [9], specificity is still a concern. New research has suggested
more specific means of inhibition may be achieved by preventing
MAPK substrate docking [10,11]. Docking events are guided by
docking motifs on substrate proteins that interact with counter-
regions on MAPKs [12]. Multiple consensus MAPK substrate
docking patterns have been proposed for eukaryotes, although
some exceptions to these patterns do exist [13]. Recently, small-
molecule inhibitors that target calcineruin phosphatase activity by
disrupting docking showed success [14]. With knowledge of
docking sites on HIV, small-molecule inhibitors might be
developed to disrupt HIV protein phosphorylation by MAPKs,
preventing HIV replication. However, care must be taken when
designing HIV drugs because of strain diversity.
HIV strains are classified hierarchically, starting with three
groups: major (M), outlier (O), and non-major and non-outlier (N).
Group M, which is the most common, has been divided into nine
subtypes, or clades: A, B, C, D, F, G, H, J and K. Recombinant
forms of group M subtypes have been identified. For instance,
01_AE is a combination of subtypes A and E that is circulating in
Southeast Asia [15]. Five subtypes and two recombinants are
present in at least 2.5% of the world population, making subtype
diversity an issue for drug and vaccine design. HIV subtype has
been found to influence transmission and disease progression [15].
The presence and absence of short motifs on HIV proteins has
been correlated with patient response to certain therapies [16],
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be considered when designing drugs.
In this study, we examine ERK1/2 docking with HIV proteins
from a drug design perspective using multiple alignments of HIV
proteins classified according to subtype. We find that only Nef has
a consensus MAPK docking site pattern on the most common
HIV strains (A1, B, and C). Some of the most frequently observed
subtypes of HIV proteins MA, Tat, and Vif are missing the
docking pattern most often observed in eukaryotic MAPK
substrates, whereas Rev does not show the docking pattern on
any strains. To explain MAPK docking with HIV proteins in a
strain independent manner, we impose slight revisions on the
regular expressions of previously annotated docking motifs. One
such revised motif is present in all major subtypes of HIV proteins
known to be phophorylated by ERK1/2, and is statistically
enriched among the substrates of ERK1/2. The use of in silico
docking indicates the plausibility of the candidate motifs as HIV
protein docking sites for ERK1. Our results provide a first step
Table 1. MAPK docking pattern hits on human proteins.
Motif Pattern Phos(%) ERK(%) p-val
Da [KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF] 558 (43) 56 (45) 0.299
Db [KR]{2,3}.{1,6}[ILVM].[ILVF] 513 (39) 51 (41) 0.348
Da/b - 620 (48) 69 (56) 0.030
Dc [KR].{2,6}[ILVM].[ILVF] 841 (65) 92 (75) 0.007
Dd [KR].{1,3}[KR]{2} 694 (53) 70 (57) 0.231
Using each of the MAPK docking site patterns, we scanned phosphorylated
substrates in dbPTM. We show the number of substrates with pattern matches
as well as results for ERK1/2 substrates. We used Fisher’s test to calculate a p-
value for the enrichment of pattern hits on ERK1/2 substrates compared to all
other phosphorylated proteins. The standard docking site patterns, Da and Db,
were not enriched on ERK1/2 substrates, but the union of these patterns was
enriched. Dc, but not Dd, was found to be enriched on ERK1/2 substrates.
doi:10.1371/journal.pone.0008942.t001
Figure 1. D-site pattern hits on HIV proteins. Hits for the standard MAPK docking sites, Da and Db, and the proposed MAPK docking sites
patterns, Dc and Dd, are annotated in purple on multiple sequence alignments of HIV proteins MA, Nef, Rev, Tat, and Vif. Subtypes in each alignment
are represented by different colors: A1 is pink, B is blue, and C is green. Note that motif annotations occur in roughly the same position within a virus
subtype.
doi:10.1371/journal.pone.0008942.g001
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await experimental verification.
Results
Consensus MAPK Docking Sites on Human Proteins
MAPK docking site sequences, found in most eukaryotic
MAPK substrates, are presented as two distinct patterns, dubbed
LIG_MAPK_1 and LIG_MAPK_2, by the Eukaryotic Linear
Motif (ELM) Resource [13]. The LIG_MAPK_2 pattern was not
considered in this analysis because it was not found to be enriched
in human ERK1/2 substrates, and it was not expressed by the
HIV proteome (data not shown). The LIG_MAPK_1, or D-site,
pattern has two functional regions: a string with two or three basic
residues and a chain of alternating hydrophobic residues [12]. One
to six residues maintain distance between these regions, helping
them interact with distinct regions on MAPKs [17]. The basic
component of the motif interacts with MAPKs at a patch of acidic
residues, called the common docking (CD) site, while the
hydrophobic region of the D-site interacts with a hydrophobic
groove close to the CD site [18]. The ELM Resource describes
one version of the D-site (Da), while the current literature contains
another frequently observed MAPK docking motif (Db), with a
regular expression similar, but not identical, to that of Da [12].
Both of the Da and Db motifs have the same biochemical
foundations (Table 1). The regular expressions of docking motifs
Da and Db were kept inclusive to account for MAPK induced
phosphorylation in multiple eukaryotic species. Nonetheless, these
motifs can serve as starting templates for the discovery of HIV
sequences involved in docking to ERK1/2.
To determine the use of docking sites in the human proteome,
we scanned proteins with documented phosphorylation sites [19]
and ERK1/2 substrates [19] with the Da and Db docking site
patterns, filtering out pattern hits falling in Pfam domains [20] in a
manner similar to the one used by the ELM Resource. The results
presented in Table 1 indicated that the Da U Db pattern was
enriched on ERK1/2 substrates relative to all phosphorylated
substrates (p,0.03). This statistical enrichment provided evidence
supporting the validity of the Da U Db pattern as the MAPK
docking site motif among human proteins.
MAPK Docking Sites on HIV Proteins
Since ERK1/2 substrates were statistically enriched with
MAPK docking motifs, we hypothesized that the presence of
these docking sites on most sequences of HIV proteins MA, Nef,
Rev, Tat, and Vif would explain their reported phosphorylation
by ERK1/2. Therefore, we searched for the MAPK docking site
patterns on HIV sequences gathered from the Los Alamos
National Lab (LANL) HIV Sequence Database (http://www.hiv.
lanl.gov/), which contains thousands of sequences spanning
multiple subtypes and recombinant forms. In this analysis, we
considered HIV strains with at least 50 sequences for all HIV
proteins known to interact with ERK1/2, leaving three strains to
consider: A1, B, and C. These subtypes are responsible for the
majority of the HIV infection around the globe [21]. Figure 1
shows the Da and Db motif annotations on multiple sequence
alignments of HIV proteins, and Table 2 shows the percentages of
HIV subtype sequences with docking site matches. The results
showed a subtype dependence for the annotations of the Da and
Db patterns along HIV proteins.
More than 90% of Nef sequences had the Da motif regardless of
subtype, but this motif was absent on most Tat and Rev sequences.
Vif subtypes A1 and C, but not B, expressed the Da motif. On the
other hand, the Db motif was present on Nef, Tat, and subtype C
of Vif, but was absent on MA and Rev. The Da and Db motifs
occupied different spatial positions along the HIV proteins. The
data shown in Figure 1 suggested Nef was the only HIV protein for
which phosphorylation by ERK1/2 could be explained by a
standard docking site.
Next we revised the Da and Db regular expressions in an
attempt to find a motif that would be present on all major
subtypes of HIV proteins known to interact with human ERK1/
2. We looked at sequences of virus proteins without a docking
motif coincident with the spatial position of the standard motifs.
Specifically, we looked at regions along MA and Vif that aligned
with the Da motif, as well as regions of Tat and Vif that aligned
Table 2. MAPK docking pattern hits on HIV proteins.
A(Da) B(Db)
VP A1 B C Total VP A1 B C Total
MA 61 45 03 4 MA 1111
Nef 97 89 98 93 Nef 96 89 91 90
Rev 19 1 3 Rev 0010
Tat 00 0 0 Tat 67 91 44 59
Vif 92 6 97 50 Vif 1 5 61 27
C(Dc) D(Dd)
VP A1 B C Total VP A1 B C Total
MA 95 96 96 96 MA 95 99 97 97
Nef 100 100 100 100 Nef 60 92 86 87
Rev 100 99 96 97 Rev 100 100 100 100
Tat 69 93 45 61 Tat 100 99 100 99
Vif 100 100 100 100 Vif 92 87 100 92
We searched sequences of HIV proteins using the four MAPK docking site patterns in Table 1. Here we present the percentages of HIV subtype sequences with these
docking site patterns. The Da and Db patterns were found on the majority of Nef sequences, but they were missing from some subtypes of the other HIV proteins. The
Dc pattern occurred on the majority of MA, Nef, Rev, and Vif subtypes. The Dd motif had hits on most sequences of all HIV proteins.
doi:10.1371/journal.pone.0008942.t002
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subtypes A1 and C of MA and subtype B of Vif was caused by a
missing basic residue. The absence of Db in some subtypes
appeared to be due to mutated hydrophobic residues. Taking
clues from these perturbations, we designed a new regular
expression for a candidate MAPK docking motif along HIV
proteins (Table 1), and represented this motif with the symbol Dc.
The motif Dc turned out to be present on HIV proteins Nef, Rev,
Tat, Vif, and MA in a relatively strain independent manner
(Figure 1).
We also considered whether or not an infrequently observed
MAPK docking motif among human proteins could serve as an
HIV strain-independent MAPK docking site. The docking site for
MAPK with thyroid hormone receptor-beta1 (TRb1) is
KGFFRR. The motif is known to be fully functional, and yet it
is missing the hydrophobic portion of the Da and Db motifs [22].
Furthermore, mutational studies showed that only the first and
final two basic residues were required for docking, yielding the
pattern KXXXRR, where X represents any amino acid [22].
Scanning this motif along the HIV proteome provided new hits,
but did not have sufficient coverage along MA, Rev, Tat, and Vif
subtypes. We expanded this pattern to include all basic residues in
the first and final two amino acids, and allowed variation in the
distance between the basic components, resulting in motif Dd, with
the regular expression given in Table 1. We used this new pattern
to scan multiple alignments of HIV proteins, and found hits on the
majority of sequences for all HIV proteins known to interact with
MAPK (Figure 1, Table 2).
Figure 2. Human sequence logos. For the four MAPK docking sites in the study, we show sequence logos for hits on human proteins. The motifs
used here allowed matches with varying lengths. The percentage of motif instances of a certain length is shown above each logo.
doi:10.1371/journal.pone.0008942.g002
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different in human and HIV proteins, and this could best be
observed by constructing sequence logos from the motif hits on
human (Figure 2) and HIV (Figure 3) proteins known to be
phosphorylated by ERK1/2. It was clear from Figures 2 and 3
that the residue usage for motifs Da, Db,a n dDc was similar
because all motif hits had basic residues followed by
hydrophobic residues. This similar biochemical foundation
explained why the candidate docking motif Dc was coincident
with Da or Db in the HIV proteome. Our computations based
on Fisher’s exact test showed the Dc motif to be statistically
enriched on ERK1/2 binding partners (Table 1). The fact that
the Da, Db, Dc motif hits on HIV proteins allow less variation
in the spacing residues makes it possible to target these regions
with small-molecule drugs while preserving host ERK1/2
activity. The Dd motif had more or less the same residue usage
in human and HIV proteins. This motif is a simple one, and
was not statistically enriched among ERK1/2 substrates
(Table 1).
Candidate Docking Motifs on the HIV Protein Matrix
Supported by Structures
In order to further support the feasibility of our new docking
patterns as MAPK docking sites, we compared the structures of
the HIV matrix protein to those of ERK1/2 substrates. We
chose MA in this comparison due to the availability of multiple
structures for this protein. Figure 4 shows the hierarchical
clustering of the HIV MA proteins and ERK1/2 substrates
Figure 3. HIV Sequence logos. For each MAPK docking site motif, we gathered all hits on all HIV proteins and constructed sequence logos for hits
with the same length. The percentage of motif instances of a certain length is shown above each logo.
doi:10.1371/journal.pone.0008942.g003
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measured by the TM-score. As explained in the methods
section, the TM-score is a normalized measure of structural
similarity that ranges between 0 and 1, where a score above 0.20
is considered significant [23]. As expected by their 90%
sequence similarity, the HIV MA proteins (shown in bold in
Figure 4) were clustered together at a high TM-score (0.65).
Surprisingly, some of the human MAPK substrates (specifically,
Mcl-1, Tob1, and the Xenopus STAR/GSG quaking protein)
were found to be structurally more similar to HIV MA proteins
than they were to other MAPK substrates. These results were
consistent with experimental data showing binding between
ERK1/2 and HIV MA.
We next performed in silico docking between MA and ERK1
using the ZDOCK server [24]. ZDOCK allows users to force
binding between specific residues. The top panel of Figure 5 shows
ERK1 docked with MA when binding was forced between the
hydrophobic portion of Dc and the hydrophobic groove of ERK1.
The bottom panel of Figure 5 shows ERK1 docked with MA after
binding was forced between the Dd motif on MA and the CD site
on ERK1 [25]. This figure demonstrates the close proximity of the
MA docking site and the ERK1 docking groove. The ATP binding
site of ERK1 is bound by the MAPK inhibitor 5-iodotubericidin,
colored yellow. Both docking experiments positioned possible
phosphorylation sites on MA close to the ATP binding site of
ERK1, adding additional evidence that the Dc and Dd patterns on
MA could be functional. This is demonstrated in more detail in
YASARA (http://www.yasara.org) scenes of the complexes
(YASARA S1).
Discussion
In this study we have shown that known MAPK docking motifs
occur in a strain dependent manner on HIV proteins known to
interact with human ERK1/2. MAPK substrate docking is known
to facilitate phosphorylation. While the detailed role of MAPK
phosphorylation in HIV infection has not been established in a
clinical setting, ERK1/2 phosphorylation of HIV proteins has
been associated with viral infectivity in a number of in vitro studies,
highlighting the importance of MAPK docking sites in the course
of HIV infection. For this reason, we hypothesized that if MAPK
phosphorylation of HIV proteins was an essential feature of the
progression of HIV infection, then MAPK docking sites along
HIV proteins would be strain independent. This was our
motivation for revising known human MAPK docking sites for
the case of HIV proteins.
Our study suggested two docking motifs, Dc, and Dd, and
showed that these appeared on all subtypes of HIV proteins
phosphorylated by ERK1/2. These motifs shared biochemical
characteristics with motifs used by human proteins that bind to
MAPKs. The Dc motif was missing one basic residue form the
standard docking motifs, while the Dd motif was missing the
Figure 4. MAPK substrate hierarchy. Here we present UPGMA
clustering of HIV MA proteins and ERK1/2 substrates by pairwise
structural alignment TM-scores. All substrates are human proteins
unless otherwise indicated. The HIV MA proteins are shown in bold.
doi:10.1371/journal.pone.0008942.g004
Figure 5. Docking between ERK1 and HIV MA. In silico docking
was performed using ZDOCK by forcing ERK1 (orange) to dock at the Dc
and Dd motifs on HIV MA (blue). In the upper panel, docking was forced
to occur between the hydrophobic tail of the Dc motif on MA and the
hydrophobic docking groove of ERK1. The lower panel shows the
resulting complex when docking was forced between the basic residues
of Dd on MA and the CD site of ERK1. The ATP binding site of ERK1
interacts with MAPK inhibitor 5-iodotubericidin (yellow). When the Dd
docking site on MA (gray) was forced to interact with ERK1, serine
phosphorylation sites (magenta) on ERK1 were positioned in close
proximity to the ERK1 ATP binding site.
doi:10.1371/journal.pone.0008942.g005
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human proteins, while the Dc motif did not. In silico docking
experiments provided evidence supporting the hypothesis that
these motifs function as MAPK docking sites along HIV proteins.
One of these candidate motifs, Dc, was statistically enriched among
the binding partners of ERK1/2. However, the lack of statistical
enrichment does not exclude the possibility of the Dd motif being
used as a docking site as well.
Current drugs target MAPK activity, but new drugs based on
the HIV MAPK docking sites might work better. Existing
MAPK drugs, like SB203580, SB202190, and RWJ67657 do
not target ERK1/2. FR180204 does target ERK1/2 activity via
the ATP binding site. New drugs targeting HIV replication by
blocking ERK1/2 phosphorylation of MA and Vif could in
theory be incorporated into existing therapy regimens, making it
more difficult for an HIV strain to acquire the mutations for
resistance to all drugs [26]. By targeting MAPK docking sites,
rather than ATP binding sites, drugs can offer more specificity.
There is hope that few ERK1/2 substrates will be targeted by
drugs specific to HIV docking sequences. Amino acid sequences
used by virus and the host in the Dc motif were significantly
different (Figures 2 and 3) to allow for specific targeting of HIV
proteins with drugs. Moreover, the poor structural alignment of
H I VM Aa n do t h e rE R K 1 / 2s u b s t r a t e ss u g g e s t st h a tH I V
specific targeting is possible.
In conclusion, the standard MAPK docking motifs from the
literature could not explain ERK1/2’s interactions with all
subtypes of HIV proteins. The two new motifs we introduced
as candidate motifs for ERK1/2 docking were present on
subtypes A1, B, and C of HIV proteins known to interact with
MAPK. The amino acid composition of the docking motifs on
HIV proteins was different enough from the composition
found on human ERK1/2 substrates to allow for HIV
sequence specific drug targeting using small-molecule drugs.
Further annotation of the proposed docking motifs will await
experimental verification. This is partly because the sequence
data used in generating regular expression patterns may
contain overrepresented residues that may have no functional
role in the motif, making it difficult to differentiate association
from functional necessity. Present computational tools are not
yet advanced enough to accurately classify functional residues
in short motifs.
Materials and Methods
Human and HIV Sequences and Motifs
HIV sequence alignments were gathered from the LANL
HIV Sequence Database, and processed according to [27], but
here only subtypes A1, B, and C. We gathered 1436 proteins
known to be phosphorylated from dbPTM [19], and found 132
of these were phosphorylated by ERK1/2. We scanned all
sequences with the four regular expressions for MAPK docking
sites. For human proteins, we attempted to rule out false positive
hits in a manner similar to the ELM Resource. We removed any
pattern hits that overlapped with a Pfam domain [20]. Pfam
domains were found for all proteins using the default settings for
the standalone Pfam scan program. Enrichment of docking site
p a t t e r nh i t so nE R K 1 / 2s u b s t r a tes was calculated with a one-
tailed Fisher’s exact test, using phosphorylated dbPTM
substrates as a background set.
Structure Analysis
We performed a BLAST [28] search on the Protein Data Bank
(PDB) [29] to identify known ERK1/2 substrate protein structures
(E-value threshold of E-10). We collected the proteins that had less
than 150 residues, to be comparable to HIV MA in size, and only
kept the top hit in each BLAST result set. A pairwise structural
alignment of each of three MA structures [PDB:1hiw, PDB:1uph,
PDB:2hmx] against each MAPK substrate structure was per-
formed using Vorometric [30]. The alignments were filtered by a
TM-score [23] of 0.25, resulting in 10 ERK1/2 substrate
structures. The PDB identifiers for the 10 substrates are as
follows: PDB:1mkpA - MAPK phosphatase Pyst1, PDB:3ezzA -
Dual specificity protein phosphatase 4, PDB:2vswA - Dual
specificity phosphatase 16, PDB:1pueE - PU.1 ETS-domain,
PDB:1duxC - Elk-1, PDB:1hksA - Drosophila heat shock
transcription factor, PDB:2pqkA - Mcl-1, PDB:2z15A - Tob1,
PDB:2bl5A - STAR/GSG quaking protein, PDB:1cmzA - GAIP,
PDB:2g5mB - Neurabin-2, PDB:1oj5A - Steroid receptor
coactivator 1A, PDB:1am9A - SREBP-1a.
Docking
For the top panel of Figure 4, the ZDOCK server (http://
zdock.bu.edu) was used to calculate the most probable complex of
ERK1 [PDB:2zoqA] and HIV MA [PDB:1uphA] when binding
was forced between the hydrophobic tail residues of the Dc motif
on MA (Ile19 and Leu21) and the hydrophobic docking groove of
ERK1 (Thr127, Leu132, Leu138, and Phe146 [25]).
For the bottom panel of Figure 4, the ZDOCK server was used
to calculate the most probable complex of ERK1 [PDB:2zoqA]
and HIV MA [PDB:1uphA] when binding was forced between the
basic residues of the Dd motif on MA (Arg22, Lys26, and Lys27)
and the CD site of ERK1 (Glu98, Asp179, Asp335, and Asp338
[25]).
Supporting Information
YASARA S1 These are the YASARA scene files showing the
ERK1/HIV MA complex determined by ZDOCK by forcing
docking at the Dc or Dd motifs on MA. Molecules are colored
according to Figure 5.
Found at: doi:10.1371/journal.pone.0008942.s001 (0.16 MB ZIP)
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